Evidence map›Paper›PMID 29222344›Full record

ArticleEMBO reports2018

TRIP6 inhibits Hippo signaling in response to tension at adherens junctions.

Shubham Dutta, Sebastian Mana-Capelli, Murugan Paramasivam, Ishani Dasgupta, Heather Cirka, Kris Billiar, Dannel McCollum

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Mechanobiology of the Hippo-YAP Signaling Network.Cold Spring Harbor perspectives in biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Principles and regulation of mechanosensing.Journal of cell science · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cortical tension promotes Kibra degradation via Par-1.Molecular biology of the cell · 2024
    Article
  13. Article
  14. Genes · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shubham DuttaDepartment of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Sebastian Mana-CapelliDepartment of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Murugan ParamasivamDepartment of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Ishani DasguptaDepartment of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Heather CirkaDepartment of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA, USA.
Kris BilliarDepartment of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA, USA.
Dannel McCollumDepartment of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA dannel.mccollum@umassmed.edu.ORCID 0000-0003-0278-2715
University of Massachusetts Chan Medical School · USWorcester Polytechnic Institute · US

Funding

Regulation of Hippo pathway signaling by mechanical forcesR01GM058406 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCCOLLUM, DANNEL · 1998 to 2023
$8.5M
NIGMS NIH HHS R01 GM058406
6 · The paper itself

Abstract

The transcriptional co-activator YAP controls cell proliferation, survival, and tissue regeneration in response to changes in the mechanical environment. It is not known how mechanical stimuli such as tension are sensed and how the signal is transduced to control YAP activity. Here, we show that the LIM domain protein TRIP6 acts as part of a mechanotransduction pathway at adherens junctions to promote YAP activity by inhibiting the LATS1/2 kinases. Previous studies showed that vinculin at adherens junctions becomes activated by mechanical tension. We show that vinculin inhibits Hippo signaling by recruiting TRIP6 to adherens junctions and stimulating its binding to and inhibition of LATS1/2 in response to tension. TRIP6 competes with MOB1 for binding to LATS1/2 thereby blocking MOB1 from recruiting the LATS1/2 activating kinases MST1/2. Together, these findings reveal a novel pathway that responds to tension at adherens junctions to control Hippo pathway signaling.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAdherens JunctionsBiomarkersCell LineGene ExpressionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHippo Signaling PathwayHumansLIM Domain ProteinsPhosphoproteinsProtein BindingProtein Serine-Threonine KinasesProtein TransportRecombinant Fusion ProteinsAdaptor Proteins, Signal TransducingBiomarkersLATS1 protein, humanLATS2 protein, humanLIM Domain ProteinsPhosphoproteinsProtein Serine-Threonine KinasesRecombinant Fusion ProteinsRNA, Small InterferingTranscription FactorsTRIP6 protein, humanTumor Suppressor ProteinsYAP1 protein, humanYAP-Signaling Proteinsadherens junctionsmechano‐sensingTRIP6VinculinYAP

Identifiers

PMID29222344
PMCPMC5797958
OpenAlexW2775778321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.